Spatially mapping the immune landscape of melanoma using imaging mass cytometry
Dan Moldoveanu,LeeAnn Ramsay,Mathieu Lajoie,Luke Anderson-Trocme,Marine Lingrand,Diana Berry,Lucas J M Perus,Yuhong Wei,Cleber Moraes,Rached Alkallas,Shivshankari Rajkumar,Dongmei Zuo,Matthew Dankner,Eric Hongbo Xu,Nicholas R Bertos,Hamed S Najafabadi,Simon Gravel,Santiago Costantino,Martin J Richer,Amanda W Lund,Sonia V Del Rincon,Alan Spatz,Wilson H Miller,Rahima Jamal,Réjean Lapointe,Anne-Marie Mes-Masson,Simon Turcotte,Kevin Petrecca,Sinziana Dumitra,Ari-Nareg Meguerditchian,Keith Richardson,Francine Tremblay,Beatrice Wang,May Chergui,Marie-Christine Guiot,Kevin Watters,John Stagg,Daniela F Quail,Catalin Mihalcioiu,Sarkis Meterissian,Ian R Watson,Lucas J.M. Perus,Nicholas R. Bertos,Hamed S. Najafabadi,Martin J. Richer,Amanda W. Lund,Sonia V. Del Rincon,Wilson H. Miller,Daniela F. Quail,Ian R. Watson
DOI: https://doi.org/10.1126/sciimmunol.abi5072
IF: 30.63
2022-04-01
Science Immunology
Abstract:Melanoma is an immunogenic cancer with a high response rate to immune checkpoint inhibitors (ICIs). It harbors a high mutation burden compared with other cancers and, as a result, has abundant tumor-infiltrating lymphocytes (TILs) within its microenvironment. However, understanding the complex interplay between the stroma, tumor cells, and distinct TIL subsets remains a substantial challenge in immune oncology. To properly study this interplay, quantifying spatial relationships of multiple cell types within the tumor microenvironment is crucial. To address this, we used cytometry time-of-flight (CyTOF) imaging mass cytometry (IMC) to simultaneously quantify the expression of 35 protein markers, characterizing the microenvironment of 5 benign nevi and 67 melanomas. We profiled more than 220,000 individual cells to identify melanoma, lymphocyte subsets, macrophage/monocyte, and stromal cell populations, allowing for in-depth spatial quantification of the melanoma microenvironment. We found that within pretreatment melanomas, the abundance of proliferating antigen-experienced cytotoxic T cells (CD8 + CD45RO + Ki67 + ) and the proximity of antigen-experienced cytotoxic T cells to melanoma cells were associated with positive response to ICIs. Our study highlights the potential of multiplexed single-cell technology to quantify spatial cell-cell interactions within the tumor microenvironment to understand immune therapy responses.
immunology